Tumour Biology - Mechanisms of Metastasis Flashcards
what is metastasis
- a metastasis is a tumour spread from its tissue of origin
- metastasis s a multifactorial process (different types of events must happen for a metastasis to occur)
- it is the major cause of death from malignant disease because widespread metastatic disease is difficult to treat
where is colorectal cancer mainly metastasised to
- The liver
correlation between grade of cancer and site of metastasis - what does the tell us about the process of metastasis
- As patients progress through the grade, the incidence of metastasis into the lung and liver increases.
- However for metastases to the bone (common site for breast cancer to spread), there is no such correlation.
- basically: patient at any grade of breast cancer can get metastasis to bone, but only at higher grades do we get metastasis to liver & lungs
- This tells us that there must be something different in the way tumour cells metastasise to different organs
what are the 4 major sub-types of breast cancer
- HR+/HER2-
- HR+/HER2+
- HR-/HER2+
- HR-/HER2-
which type of breast cancer is most likely to metastasise to bone
HR+/HER2-
- just remember that different cancers have different likelihood of metastasising to different organs
What are the key steps in the metastatic cascade and the properties of metastatic cells?
1.Vascularisation of the primary tumour (to gain blood supply).
2.Detachment of cancer cells from the primary mass.
- Invasion of the extracellular matrix (e.g. basement membrane).
- Intravasation – cells enter blood vessels.
- Survival in circulation and travel to a secondary site.
- Adhesion to endothelium of the target organ.
- Extravasation – exit from blood vessels.
- Colonisation and survival in the secondary organ, forming micrometastases → macrometastases.
what are some factors which will affect the metastatic cascade
- many factors affect the metastatic cascade, including supply of oxygen & glucose (energy)
- concentration of O2 is different in normal vs cancerous tissue (O2 levels are much higher in the normal organ vs the tumour)
how does O2 concentration differ in cancerous vs normal tissue
[O2] is lower in cancerous tissue in all cases of cancer
why is the [O2] different in cancerous tissue
the simplest explanation for this is: the proliferation of cancerous cells results in the formation of a mass - this means that they are further away from vasculature/supply of O2.
why do we get necrotic regions in bigger tumours
the bigger the mass of tumour cells, the further away some of the cells are from the supply/vasculature ⇒ less oxygen & nutrients ⇒ they will die ⇒ necrosis
cancerous cells need O2 to proliferate, so they die in hypoxia
result of hypoxia-dependant transcriptional factor development
hypoxia is important in cancer development & metastasis as the induction of powerful transcriptional factors will lead to multiple changes: (basc the hallmarks)
- immune evasion
- evasion of apoptosis
- regulation of proliferation
- regulation of angiogenesis
- self-sufficiency in growth signals
- genomic instability
- tissue invasion metastasis
- limitless replication potential
- glycolysis
how does sufficient supply of oxygen (so in normal cells) prevent angiogenesis
- in normoxia we have low concentration of transcriptional factors such as HIF-1⍺ (hypoxia induced factors) because we are oxygenating it via PHD
- oxygenated HIF-1⍺ recruits the protein pVHL
- In normoxia, the interaction between HIF and pVHL causes degradation of HIF-1⍺ through ubiquination
how do cancerous cells respond to hypoxia (4 we will focus on in the lecture)
- stimulate angiogenesis
- switch from an aerobic to an anaerobic form of energy generation (glycolysis + increase in lactate)
- immune evasion (via lactate)
- tissue invasion metastasis
describe how cancer cells cause angiogenesis + so overcome hypoxia
- HIF-⍺ (hypoxia induced factor) is stabilised as it can’t be hydroxylated anymore (no oxygen)
- in hypoxia, pVHL is S-nitrosylated and is not recognised by HIF-⍺
- so ubiquination does not take place
- so HIF-1⍺ and HIF-1β form a complex which will result in hypoxia-induced gene expression of raw angiogenic factors such as VEGF ⇒ stimulation of angiogenesis
what else can induce expression of HIF-⍺ (oxygen-independent regulation of HIF-1⍺ in cancer) (3)
- by inflammation
- cytokines (TNF-a, IFN)
- chemokines (MIF)
- growth factors (PDGF)
- direct HIF-1 activation by pathogens
- siderophores (Ybt, Sal, DFO)
- adhesins (BadA, F1845)
- LPS (E. coli)
- toxins (C. defficile)
- genetic epigenetic activation of HIF-1 expression
- oncogenic pathways (PI2-K)
- mutations
why is angiogenesis advantageous for tumour cells (+ overall diagram)
angiogenesis = the development of new blood vessels
- so the tumour cells will now have sufficient oxygen supply = promote survival as well as spread
describe the capillaries (due to angiogenesis) in normal tissue vs cancerous tissue
- Newly developed capillaries in the tumour are different from normal capillaries in the normal tissues.
- Normal Capillaries:
- Smooth, cobblestone appearance
- endothelial cells are tightly connected to each other
- Capillaries in tumours:
- abnormal endothelial cells that partition the lumen
- multiple intercellular openings
- Normal Capillaries:
- In the case of tumour vascularisation, you can see that the capillaries are not as nicely organised (they become torturous).
- This helps tumour cells get inside the vasculature.
what is the main source of energy in all cells
Glucose (being converted to ATP)
metabolism of glucose in normoxia (basically glycolysis)
- In glycolysis glucose is taken up by cells and then converted to pyruvate producing ATP (energy).
- Pyruvate is converted to acetyl co-A (and lactate) which enters the Krebs cycles (AKA TCA), this is catalysed by PDH (pyruvate dehydrogenase).
- this results in a sequence of enzymatic events which eventually leads to the production of ATP and NAD+ which enter electron transport chain (ETC)
- the ETC is where most ATP is generated
metabolism of glucose in hypoxia (2 main things happen)
we get an increase in lactate, how?:
- In the case of hypoxia, you will have HIF-1⍺ stabilized, which will:
- increased production of lactate transporter (MCT4)
- It will increase production of an enzyme called PDK1 (which phosphorylates/inactivates PDH ⇒ can’t dehydrogenate pyruvate).
- As a result of this, in hypoxic conditions, you get pyruvate converted to lactate.
- This inhibits production of Acetyl-CoA and so you get blockage of pyruvate entering the Krebs cycle.
is glycolysis an efficient way of generating energy?
- Glycolysis is an inefficient way of energy generation as when you block the Krebs cycle the number of ATP molecules produced will be significantly lower.
- But glycolysis allows cells to survive in hypoxic conditions, and then when you have new vasculature formed you will have better supply of glucose and oxygen and so you get switching back to aerobic cycle.
why is glycolysis advantageous for cancer cell survival
- Upregulation of glycolysis in tumour cells enables tumour cells to outcompete normal cells for scarce glucose supply
- Tumour cells use glycolysis are a major route of energy generation.
- They also upregulate glycose uptake and metabolism:
- They upregulate the glucose transporters which enables them to scavenge very effectively for glucose in the extracellular environment
- They also upregulate the enzymes such as the Hexokinases which are responsible for process of glycolysis.
what is the higher production of lactate in hypoxia known as
Warburg effect - it is very positive in cancer cells
- The Warburg Effect is defined as an increase in the rate of glucose uptake and preferential production of lactate, even in the presence of oxygen.
- This is what happens in cancer cells
- Whilst this can be stimulated by hypoxia often cancer cells will switch to using glycolysis even under normoxia conditions.
what is the advantage of the excess lactate produced by cancer cells due to the Warburg effect (4)
Lactate can regulate many things and stimulate different mechanisms which will lead its metastasis:
- tumour micro-environment (stimulate their growth)
- proposal: enhances distribution of tissue architecture and immune cell evasion
- rapid ATP synthesis
- proposal: increases access to a limited energy source
- cell signalling
- proposal: allows for signal transduction through ROS and/or chromatin modulation
- biosynthesis
- proposal: promotes flux into biosynthesitic pathways